Skip to main content

Table 4 Baseline characteristics of the patients with advanced NPC stratified by NLR

From: Prognostic value of neutrophil-to-lymphocyte ratio in advanced nasopharyngeal carcinoma: a large institution-based cohort study from an endemic area

 

No. of patients (%) stratified by NLR

 

Characteristic

≤ 2.50 (n = 813)

> 2.50 (n = 737)

P value

Age

  

0.222

  ≤ 45

404 (49.7)

343 (46.6)

 

  > 45

409 (50.3)

394 (53.4)

 

Sex

  

0.034

 Male

575 (70.7)

557 (75.6)

 

 Female

238 (29.3)

180 (24.4)

 

T stage

  

0.001

 T1

110 (13.5)

80 (10.9)

 

 T2

151 (18.6)

114 (15.5)

 

 T3

418 (51.4)

378 (51.3)

 

 T4

134 (16.5)

165 (22.4)

 

N stage

  

0.015

 N0

106 (13.0)

84 (11.4)

 

 N1

485 (59.7)

443 (60.1)

 

 N2

132 (16.2)

94 (12.8)

 

 N3

90 (11.1)

116 (15.7)

 

Overall stage

  

< 0.001

 II

189 (10.9)

143 (19.4)

 

 III

316 (38.9)

341 (46.3)

 

 IVA-B

396 (48.7)

253 (34.3)

 

Family history

  

0.574

 No

575 (70.7)

531 (72.0)

 

 Yes

238 (29.3)

206 (28.0)

 

Smoking history

  

0.402

 No

496 (61.0)

465 (63.1)

 

 Yes

317 (39.0)

272 (36.9)

 

Drinking history

  

0.247

 No

720 (88.6)

638 (86.6)

 

 Yes

93 (11.4)

99 (13.4)

 

Treatment strategy

  

0.779

 RT

89 (10.9)

76 (10.3)

 

 CCRT alone

316 (38.9)

278 (37.7)

 

 NACT+CCRT

408 (50.2)

383 (52.0)

 
  1. Abbreviation: NLR neutrophil-to-lymphocyte ratio, CCRT concurrent chemoradiotherapy, NACT neoadjuvant chemotherapy, RT radiotherapy